You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 13, 2024

ABBOTT Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ABBOTT, and what generic and branded alternatives to ABBOTT drugs are available?

ABBOTT has one hundred and eleven approved drugs.



Summary for ABBOTT
US Patents:0
Tradenames:89
Ingredients:62
NDAs:111

Drugs and US Patents for ABBOTT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott DOPAMINE HYDROCHLORIDE dopamine hydrochloride INJECTABLE;INJECTION 070656-001 Jan 24, 1989 DISCN No No ⤷  Sign Up ⤷  Sign Up
Abbott PANWARFIN warfarin sodium TABLET;ORAL 017020-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up
Abbott AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER amino acids; dextrose INJECTABLE;INJECTION 019505-002 Nov 7, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up
Abbott EUTONYL pargyline hydrochloride TABLET;ORAL 013448-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up
Abbott CALCIUM GLUCEPTATE calcium gluceptate INJECTABLE;INJECTION 083159-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ABBOTT

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-002 Dec 14, 1994 5,212,176 ⤷  Sign Up
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-003 Aug 7, 1987 5,294,615 ⤷  Sign Up
Abbott NORVIR ritonavir CAPSULE;ORAL 020680-001 Mar 1, 1996 5,635,523*PED ⤷  Sign Up
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-002 Nov 22, 1997 4,746,680*PED ⤷  Sign Up
Abbott MERIDIA sibutramine hydrochloride CAPSULE;ORAL 020632-002 Nov 22, 1997 5,436,272*PED ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for ABBOTT drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Capsules 10 mg and 15 mg ➤ Subscribe 2009-08-14
➤ Subscribe Capsules 100 mg ➤ Subscribe 2012-10-31
➤ Subscribe Tablets 100 mg ➤ Subscribe 2010-12-21
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.